MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
1-Year Return
38.15%
This Quarter Return
+16.87%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$588M
AUM Growth
+$32M
(+5.7%)
Cap. Flow
-$14.7M
Cap. Flow
% of AUM
-2.49%
Top 10 Holdings %
Top 10 Hldgs %
17.49%
Holding
244
New
49
Increased
43
Reduced
112
Closed
29
Top Buys
| 1 |
Modine Manufacturing
MOD
|
$6.67M |
| 2 |
Halozyme
HALO
|
$5.04M |
| 3 |
AppFolio
APPF
|
$4.84M |
| 4 |
Viking Therapeutics
VKTX
|
$4.57M |
| 5 |
Fabrinet
FN
|
$4.15M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$8.47M |
| 2 |
The Bancorp
TBBK
|
$7.18M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.17M |
| 4 |
Asbury Automotive
ABG
|
$5.91M |
| 5 |
ESCO Technologies
ESE
|
$4.49M |
Sector Composition
| 1 | Healthcare | 17.82% |
| 2 | Industrials | 15.19% |
| 3 | Consumer Discretionary | 13.61% |
| 4 | Financials | 13.51% |
| 5 | Technology | 13.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Amazon
AMZN
$2.51T
| $760K | 0.13% |
4,213
-106
| -2% | -$19.1K |
|
127
Neurocrine Biosciences
NBIX
$13.9B
| $671K | 0.11% |
4,863
| – | – |
|
128
East-West Bancorp
EWBC
$15B
| $634K | 0.11% |
8,011
-43
| -0.5% | -$3.4K |
|
129
Biogen
BIIB
$20.5B
| $626K | 0.11% |
2,901
-709
| -20% | -$153K |
|
130
Xenon Pharmaceuticals
XENE
$2.98B
| $622K | 0.11% |
14,451
+5,328
| +58% | +$229K |
|
131
Celldex Therapeutics
CLDX
$1.51B
| $616K | 0.1% |
14,687
| – | – |
|
132
BioMarin Pharmaceuticals
BMRN
$10.9B
| $616K | 0.1% |
7,049
| – | – |
|
133
Pfizer
PFE
$140B
| $611K | 0.1% |
+22,004
| New | +$611K |
|
134
Deckers Outdoor
DECK
$18.4B
| $560K | 0.1% |
3,570
-600
| -14% | -$94.1K |
|
135
UnitedHealth
UNH
$281B
| $554K | 0.09% |
1,119
+31
| +3% | +$15.3K |
|
136
JPMorgan Chase
JPM
$835B
| $553K | 0.09% |
2,763
-65
| -2% | -$13K |
|
137
Stryker
SYK
$151B
| $524K | 0.09% |
1,465
-157
| -10% | -$56.2K |
|
138
PepsiCo
PEP
$201B
| $509K | 0.09% |
2,910
+234
| +9% | +$41K |
|
139
Advanced Drainage Systems
WMS
$11.2B
| $499K | 0.08% |
2,898
-14
| -0.5% | -$2.41K |
|
140
Boston Scientific
BSX
$159B
| $498K | 0.08% |
7,267
-18
| -0.2% | -$1.23K |
|
141
Vermilion Energy
VET
$1.15B
| $490K | 0.08% |
39,400
+16,500
| +72% | +$205K |
|
142
Stifel
SF
$11.8B
| $479K | 0.08% |
6,129
-32
| -0.5% | -$2.5K |
|
143
IQVIA
IQV
$31.3B
| $475K | 0.08% |
1,878
+202
| +12% | +$51.1K |
|
144
Pultegroup
PHM
$27.2B
| $475K | 0.08% |
3,935
-21
| -0.5% | -$2.53K |
|
145
Blackstone
BX
$133B
| $472K | 0.08% |
3,595
-92
| -2% | -$12.1K |
|
146
Howmet Aerospace
HWM
$72.4B
| $471K | 0.08% |
6,890
-36
| -0.5% | -$2.46K |
|
147
WEX
WEX
$5.94B
| $460K | 0.08% |
1,936
-12
| -0.6% | -$2.85K |
|
148
Bio-Techne
TECH
$8.23B
| $454K | 0.08% |
6,455
+104
| +2% | +$7.32K |
|
149
Medpace
MEDP
$13.6B
| $449K | 0.08% |
+1,110
| New | +$449K |
|
150
Sarepta Therapeutics
SRPT
$1.93B
| $432K | 0.07% |
3,335
-3,821
| -53% | -$495K |
|